A Novel Non-agonist Peroxisome Proliferator-activated Receptor γ (PPARγ) Ligand UHC1 Blocks PPARγ Phosphorylation by Cyclin-dependent Kinase 5 (CDK5) and Improves Insulin Sensitivity

Thiazolidinedione class of anti-diabetic drugs which are known as peroxisome proliferator-activated receptor γ (PPARγ) ligands have been used to treat metabolic disorders, but thiazolidinediones can also cause several severe side effects, including congestive heart failure, fluid retention, and weig...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Choi, Sun-Sil, Kim, Eun Sun, Koh, Minseob, Lee, Soo-Jin, Lim, Donghyun, Yang, Yong Ryoul, Jang, Hyun-Jun, Seo, Kyung-ah, Min, Sang-Hyun, Lee, In Hee, Park, Seung Bum, Suh, Pann-Ghill, Choi, Jang Hyun
Format: Artigo
Idioma:Inglês
Publicat: American Society for Biochemistry and Molecular Biology 2014
Matèries:
Metabolism
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4176243/
https://ncbi.nlm.nih.gov/pubmed/25100724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M114.566794
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars